Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

TNF-alpha inhibitors can cause various immune-related skin issues.

Beta-blockers can cause rare skin side-effects, which usually improve after stopping the medication.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

A child had a rare case of scarring hair loss with skin disease, which is hard to treat and stressful.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Lupus can look like hair loss from alopecia areata but needs different treatment.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Frontal fibrosing alopecia can affect men's beards and leads to permanent hair loss.

The patient has frontal fibrosing alopecia (FFA).

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Blocking IL-17 might help treat the hair loss condition Lichen planopilaris.

The Nd:YAG laser is a successful and safe way to treat ingrown and pincer nails.

Some people may temporarily lose more hair in certain areas after a hair transplant.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Early detection of Graham-Little-Piccardi-Lasseur syndrome is key for better management.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.